Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome

Experimental and Therapeutic Medicine

Volumn 6, Issue 3, 2013, Pages 715-720

  Han, Baojuan ^a  

^a Xingtai People's Hospital   (China)

Author keywords

Anxiety depression; Gastrointestinal hormones; Irritable bowel syndrome; Somatostatin; Vasoactive intestinal peptide

Indexed keywords

GASTROINTESTINAL HORMONE; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; COLON MUCOSA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIXED ANXIETY AND DEPRESSION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

EID: 84880476661     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1211     Document Type: Article

References (25)

1. Olden KW and Schuster MM: Irritable bowel syndrome. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Feldman M, Scharschmidt BF and Sleisenger MH (eds) W.B. Saunders Co., Philadelphia, pp1536-1547, 1998.
2. Kanazawa M, Hongo M and Fukudo S: Visceral hypersensi-tivity in irritable bowel syndrome. J Gastroenterol Hepatol 26 (Suppl 3): 119-121, 2011.
3. Zhao Y, Ke M, Wang Z, Wei J, Zhu L, Sun X and Zhang J: Pathophysiplogical and psychosocial study in patients with functional vomiting. J Neurogastroenterol Motil 16: 274-280, 2010.
4. Zung WW: A self-rating depression scale. Arch Gen Psychiatry 12: 63-70, 1965.
5. Zung WW: A rating instrument for anxiety disorders. Psychosomatics 12: 371-379, 1971.
6. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F and Spiller RC: Functional bowel disorders. Gastroenterology 130: 1480-1491, 2006.
7. Fishbain D: Evidence-based data on pain relief with antide-pressants. Ann Med 32: 305-316, 2000.
8. Caso JR, Leza JC and Menchén L: The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models. Curr Mol Med 8: 299-312, 2008.
9. Crowell MD, Harris L, Jones MP and Chang L: New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 7: 272-279, 2005.
10. Binimelis J, Webb SM and Monés J: Somatostatin and irritable bowel syndrome. Lancet 2: 1533, 1987.
11. Wouters MM and Boeckxstaens GE: Neuroimmune mechanisms in functional bowel disorders. Neth J Med 69: 55-61, 2011.
12. Spiller R: Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 19 (Suppl 2): 25-31, 2007.
13. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S and Jones M: Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci 53: 108-115, 2008.
14. Camilleri M and Fealy RO: Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease: A causal association? Dig Dis Sci 35: 609-616, 2008.
15. Smart HL and Atkinson M: Abnormal vagal function in irritable bowel syndrome. Lancet 2: 475-478, 1987.
16. Ringel Y, Sperber AD and Drossman DA: Irritable bowel syndrome. Annu Rev Med 52: 319-338, 2001.
17. Simrén M, Abrahamsson H and Björnsson ES: An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 48: 20-27, 2001.
18. Liebregts T, Adam B, Bredack C, et al: Immune activation in patients with irritable bowel syndrome. Gastroenterology 132: 913-920, 2007.
19. Drossman DA: Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut 54: 569-573, 2005.
20. Gonçalves L, Almeida A and Pertovaara A: Pronociceptive changes in response properties of rostroventromedial medullary neurons in a rat model of peripheral neuropathy. Eur J Neurosci 26: 2188-2195, 2007.
21. Spence MJ and Moss-Morris R: The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 56: 1066-1071, 2007.
22. Ladep NG, Obindo TJ, Audu MD, Okeke EN and Malu AO: Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 12: 7844-7847, 2006.
23. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ and Hutchinson IV: Interleukin 10 genotypes in irritable bowel syndrome: evidence for an infammatory component? Gut 52: 91-93, 2003.
24. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501, 2000.
25. Kronfol Z and Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157: 683-694, 2000.